New Features information at Pharmaceutical Technology New and updated information from Features listed on www.pharmaceutical-technology.com http://www.pharmaceutical-technology.com/ en-us http://www.pharmaceutical-technology.com/ New Features information at Pharmaceutical Technology http://www.pharmaceutical-technology.com/content/images/logo_big.gif Pharma Technology Focus – Issue 63 http://www.pharmaceutical-technology.com/features/featurepharma-technology-focus-issue-63-5930540/ http://www.pharmaceutical-technology.com/features/featurepharma-technology-focus-issue-63-5930540/ In this issue: UK pharma industry takes NICE to court over price caps, Amazon’s potential to enter the US pharmacy industry, a new platform to capture molecules from fungi, the current state of drug development in osteoporosis, and more. Wed, 20 Sep 2017 14:52:00 GMT Mining fungi: a fountain of new medicines? http://www.pharmaceutical-technology.com/features/featuremining-fungi-a-fountain-of-new-medicines-5919883/ http://www.pharmaceutical-technology.com/features/featuremining-fungi-a-fountain-of-new-medicines-5919883/ While fungi are a rich source of natural molecules, it has historically been hard to identify and capture these in a systematic way. Now a new technology platform, developed by researchers at Northwestern University and their partners, promises to sp… Mon, 18 Sep 2017 23:00:00 GMT Osteoporosis breakthrough: positive news in a field plagued by bad press http://www.pharmaceutical-technology.com/features/featureosteoporosis-breakthrough-positive-news-in-a-field-plagued-by-bad-press-5921473/ http://www.pharmaceutical-technology.com/features/featureosteoporosis-breakthrough-positive-news-in-a-field-plagued-by-bad-press-5921473/ A new study has shown that the use of a common osteoporosis drug with anti-inflammatory medication is linked to a lower risk of hip fracture. This is just one of a range of exciting developments in the field, which also include the approval of a new … Wed, 13 Sep 2017 23:00:00 GMT 1 in 5: why the UK pharma industry is going to court over spending caps http://www.pharmaceutical-technology.com/features/featureone-in-five-why-the-uk-pharma-industry-is-going-to-court-over-spending-caps-5921092/ http://www.pharmaceutical-technology.com/features/featureone-in-five-why-the-uk-pharma-industry-is-going-to-court-over-spending-caps-5921092/ The ABPI is taking UK drug regulator NICE to court over new spending caps, which will affect one in five of all new approved drugs. Abi Millar looks into the issues surrounding this important legal contest. Mon, 11 Sep 2017 23:00:00 GMT August's top stories: Mylan launched anti-retroviral treatments, Fosun updated on $1.3bn takeover http://www.pharmaceutical-technology.com/features/featureaugust-2017-top-news-stories-pharmaceutical-5910543/ http://www.pharmaceutical-technology.com/features/featureaugust-2017-top-news-stories-pharmaceutical-5910543/ Mylan launched three generic anti-retroviral treatments for HIV patients in Canada, and Fosun updated on $1.3bn takeover of Indian drugmaker Gland Pharma. Pharmaceutical-technology.com wraps up the key headlines from August. Mon, 04 Sep 2017 23:00:00 GMT Is Amazon gearing up to take on the US pharmacy market? http://www.pharmaceutical-technology.com/features/featureis-amazon-gearing-up-to-take-on-the-us-pharmacy-market-5915816/ http://www.pharmaceutical-technology.com/features/featureis-amazon-gearing-up-to-take-on-the-us-pharmacy-market-5915816/ Reports that Amazon is considering breaking into the US pharmacy industry have sent ripples up and down the drug supply chain. Is there enough evidence to suggest that the retail and tech giant is truly serious about making such a move, and what coul… Mon, 04 Sep 2017 07:00:00 GMT Pharma Technology Focus – Issue 62 http://www.pharmaceutical-technology.com/features/featurepharma-technology-focus-issue-62-5907980/ http://www.pharmaceutical-technology.com/features/featurepharma-technology-focus-issue-62-5907980/ In this issue: A new tool to encourage links between industry and academia, blockchain’s applications for pharma, using Zika to attack brain tumour cells, treating MS with nanotechnology, the benefits of publicly funded cancer trials, and more. Wed, 23 Aug 2017 13:20:00 GMT Zika virus: an unlikely new anti-cancer candidate http://www.pharmaceutical-technology.com/features/featurezika-virus-an-unlikely-new-anti-cancer-candidate-5905375/ http://www.pharmaceutical-technology.com/features/featurezika-virus-an-unlikely-new-anti-cancer-candidate-5905375/ Scientists at Cambridge University, funded by Cancer Research UK, are investigating the potential for Zika virus to be weaponised against brain tumour cells. The researchers have received funding to test the effect of Zika on glioblastoma, one of the… Sun, 20 Aug 2017 23:00:00 GMT New library building the LINC between pharmaceutical industry and academia http://www.pharmaceutical-technology.com/features/featurenew-library-building-the-linc-between-pharmaceutical-industry-and-academia-5885401/ http://www.pharmaceutical-technology.com/features/featurenew-library-building-the-linc-between-pharmaceutical-industry-and-academia-5885401/ Stronger links between industry and academia could speed up the process of developing new medicines. Elly Earls investigates a new tool developed by the Association of the British Pharmaceutical Industry designed to encourage just that. Mon, 07 Aug 2017 23:00:00 GMT July's top stories: Researchers found epithelial cells prevent Ebola, Mitsubishi agreed to buy NeuroDerm http://www.pharmaceutical-technology.com/features/featureaugusts-top-stories-5889730/ http://www.pharmaceutical-technology.com/features/featureaugusts-top-stories-5889730/ A research team discovered epithelial cells in the eyes can prevent the spread of Ebola, and Mitsubishi Tanabe Pharma agreed to buy NeuroDerm for $1.1bn. Pharmaceutical-technology.com wraps up the key headlines from July. Sun, 06 Aug 2017 23:00:00 GMT Closing the US pharmaceutical industry’s growing skills gap http://www.pharmaceutical-technology.com/features/featureclosing-the-us-pharmaceutical-industrys-growing-skills-gap-5885395/ http://www.pharmaceutical-technology.com/features/featureclosing-the-us-pharmaceutical-industrys-growing-skills-gap-5885395/ The US pharmaceutical industry will face a huge shortage of skilled workers if policy makers don’t up their game in the face of growing competition from other countries. Elly Earls meets PhRMA’s vice president of policy and research, Anne Pritchett, … Sun, 30 Jul 2017 23:00:00 GMT PhRMA: resetting the conversation http://www.pharmaceutical-technology.com/features/featurephrma-resetting-the-conversation-5880995/ http://www.pharmaceutical-technology.com/features/featurephrma-resetting-the-conversation-5880995/ A new requirement launched by US industry association PhRMA is mandating a minimum R&D spend by all members. The move sits at the core of the group’s campaign to revitalise the pharma sector’s public image and strengthen its stance on drug pricing, b… Tue, 25 Jul 2017 23:00:00 GMT Do healthcare cuts risk creating a ‘desert for innovation’ in the UK? http://www.pharmaceutical-technology.com/features/featuredo-healthcare-cuts-risk-creating-a-desert-for-innovation-in-the-uk-5864811/ http://www.pharmaceutical-technology.com/features/featuredo-healthcare-cuts-risk-creating-a-desert-for-innovation-in-the-uk-5864811/ The pharmaceutical industry has warned that drug firms could abandon the UK if healthcare spending isn’t significantly increased. We find out exactly what the sector wants from the government’s healthcare investment and how this will stop the UK beco… Sun, 23 Jul 2017 23:00:00 GMT Betting big on Gamma Delta T Cells http://www.pharmaceutical-technology.com/features/featurebetting-big-on-gamma-delta-t-cells-5864573/ http://www.pharmaceutical-technology.com/features/featurebetting-big-on-gamma-delta-t-cells-5864573/ A novel development platform being developed by a British biotech could lead to new treatments for cancer and auto-inflammatory diseases. Elly Earls finds out why drug giant Takeda is betting big on its potential. Thu, 20 Jul 2017 09:27:00 GMT Pharma Technology Focus – Issue 61 http://www.pharmaceutical-technology.com/features/featurepharma-technology-focus-issue-61-5875781/ http://www.pharmaceutical-technology.com/features/featurepharma-technology-focus-issue-61-5875781/ In this issue: The UK’s healthcare spending problem, PhRMA’s new R&D spending requirements, undermining supply chain security by importing foreign drugs, milestone cystic fibrosis trials, a personalised treatment approach for panic disorder, and more… Wed, 19 Jul 2017 13:55:00 GMT Cystic fibrosis: searching for a breakthrough http://www.pharmaceutical-technology.com/features/featurecystic-fibrosis-searching-for-a-breakthrough-5874315/ http://www.pharmaceutical-technology.com/features/featurecystic-fibrosis-searching-for-a-breakthrough-5874315/ The last few months have provided some encouraging news for the cystic fibrosis patient community, with milestone trials from the likes of Vertex Pharmaceuticals and Anthera Pharmaceuticals meeting their clinical endpoints. Chris Lo profiles the drug… Tue, 18 Jul 2017 23:00:00 GMT US drug imports: a recipe for disaster? http://www.pharmaceutical-technology.com/features/featureus-drug-imports-a-recipe-for-disaster-5852374/ http://www.pharmaceutical-technology.com/features/featureus-drug-imports-a-recipe-for-disaster-5852374/ With US prescription drug prices among the highest in the world, legislation has been proposed that would allow cheaper foreign imports. However, opponents say this would undermine supply chain security and compromise drug quality. Abi Millar explore… Sun, 16 Jul 2017 23:00:00 GMT Treating mononucleosis: why the mystery? http://www.pharmaceutical-technology.com/features/featuretreating-mononucleosis-why-the-mystery-5688881/ http://www.pharmaceutical-technology.com/features/featuretreating-mononucleosis-why-the-mystery-5688881/ Mononucleosis, a common condition usually caused by the Epstein- Barr vVirus, affects millions but has no cure or vaccine, and has a high risk of misdiagnosis. So what is being done to improve the situation? Abi Millar reports. Wed, 12 Jul 2017 23:00:00 GMT Reforming paediatric cancer trials in Europe http://www.pharmaceutical-technology.com/features/featurereforming-paediatric-cancer-trials-in-europe-5852474/ http://www.pharmaceutical-technology.com/features/featurereforming-paediatric-cancer-trials-in-europe-5852474/ Outdated European regulations are depriving children of access to the latest cancer treatments. Elly Earls asks the ICR’s Dr Eva Sharpe why now is the time for reform and how the rules need to change. Sun, 09 Jul 2017 23:00:00 GMT Immuno-oncology: where to go in a packed field http://www.pharmaceutical-technology.com/features/featureimmuno-oncology-where-to-go-in-a-packed-field-5839060/ http://www.pharmaceutical-technology.com/features/featureimmuno-oncology-where-to-go-in-a-packed-field-5839060/ Over the last decade or so, immuno-oncology has gained a reputation as one of the most exciting areas in medicine. Referring to treatments that harness the immune system in the fight against cancer, it has grown from a niche and somewhat speculative … Wed, 05 Jul 2017 23:00:00 GMT